Summary
- Current Price
- As of today, LRMR price is $3.20, down -12.57% on
- Current Price All-Time High
- LRMR price is currently -94.22% below its historical high of $55.36 set on
- Market Cap
- LRMR current market cap is $332M, up +71.35% over the past 365 days
- PE Ratio
- LRMR PE ratio is unknown
- Revenue
- LRMR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for LRMR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Larimar Therapeutics, Inc. |
| Ticker | NASDAQ: LRMR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | larimartx.com |
| Employees | 65 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $3.20 | ||
| Price, 1D Change | -12.57% | |
| $332M | ||
| - | ||
| - | ||
| 1.74 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.26 | ||
| EPS, 1Y Change | -72.02% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ZFGN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.26 | ||
| EPS Estimate | N/A | -$1.61 |
| EPS Est. Change | N/A | +28.94% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $3.20 | ||
| Price Target | - | $13.00 |
| Price Tgt. Change | - | +306.25% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.22 | -$1.32 | -8.05% | |
| -$1.99 | -$2.26 | -13.57% | |
| -$1.61 | N/A | +28.94% | |
| -$1.17 | N/A | +48.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $58.30M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +5.61% | ||
| +2.24% | ||
| +71.35% | ||
| +145.45% | ||
| 0.00% | ||
| 0.00% | ||
| -72.02% | ||
| -64.92% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $3.20 | ||
| $3.98 | ||
| $3.79 | ||
| $3.93 | ||
| $3.74 | ||
| -$0.06 | ||
| 1.74 | ||
| $0.29 | ||
| 39.73 | ||
| 84.42% | ||
| 110.30% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.26 | ||
| $0.00 | ||
| - | ||
| -$172.50M | ||
| - | ||
| -$165.67M | ||
| - | ||
| -$172.15M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.05 | ||
| 2.19 | ||
| 2.19 | ||
| - | ||
| - | ||
| -4.49 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 2.10 | ||
| -0.79 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $78.08M | ||
| $136.85M | ||
| $146.46M | ||
| $142.02M | ||
| $68.37M | ||
| $64.80M | ||
| $4.07M | ||
| $1.11M | ||
| $5.22M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $165.67M | ||
| $172.50M | ||
| $0.00 | ||
| $0.00 | ||
| $350.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$113.20M | ||
| $100.31M | ||
| $65.09M | ||
| $91.00K | ||
| -$113.29M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | ||
| Wedbush | → | |
| Wedbush | → | |
| Wedbush | → | |
| Wedbush | → | |
| Citigroup | → | |
| Oppenheimer | → | |
| Wedbush | → | |
| Baird | → | |
| JMP Securities | → |
Analyst sentiment
Institutional ownership
Screeners with LRMR
FAQ
What is the ticker symbol for Larimar Therapeutics, Inc.?
The ticker symbol for Larimar Therapeutics, Inc. is NASDAQ:LRMR
Does Larimar Therapeutics, Inc. pay dividends?
No, Larimar Therapeutics, Inc. does not pay dividends
What sector is Larimar Therapeutics, Inc. in?
Larimar Therapeutics, Inc. is in the Healthcare sector
What industry is Larimar Therapeutics, Inc. in?
Larimar Therapeutics, Inc. is in the Biotechnology industry
What country is Larimar Therapeutics, Inc. based in?
Larimar Therapeutics, Inc. is headquartered in United States
When did Larimar Therapeutics, Inc. go public?
Larimar Therapeutics, Inc. initial public offering (IPO) was on June 19, 2014
Is Larimar Therapeutics, Inc. in the S&P 500?
No, Larimar Therapeutics, Inc. is not included in the S&P 500 index
Is Larimar Therapeutics, Inc. in the NASDAQ 100?
No, Larimar Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Larimar Therapeutics, Inc. in the Dow Jones?
No, Larimar Therapeutics, Inc. is not included in the Dow Jones index
When was Larimar Therapeutics, Inc. last earnings report?
Larimar Therapeutics, Inc.'s most recent earnings report was on May 14, 2026
When does Larimar Therapeutics, Inc. report earnings?
The next expected earnings date for Larimar Therapeutics, Inc. is August 13, 2026
Data Sources & References
- LRMR Official Website larimartx.com
- LRMR Profile on Yahoo Finance finance.yahoo.com/quote/LRMR
- LRMR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/lrmr